TY - JOUR
T1 - The emerging role of exercise and health counseling in patients with acute leukemia undergoing chemotherapy during outpatient management
AU - Jarden, Mary
AU - Adamsen, Lis
AU - Kjeldsen, Lars
AU - Birgens, Henrik
AU - Tolver, Anders
AU - Christensen, Jesper Frank
AU - Stensen, Merete
AU - Sørensen, Vivi-Ann
AU - Møller, Tom
N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.
PY - 2013
Y1 - 2013
N2 - This study investigates the feasibility, safety and benefits of a 6-week exercise and health counseling intervention in patients with acute leukemia undergoing consolidation chemotherapy during outpatient management. Seventeen of twenty patients completed study requirements (85%), adherence to exercise was 73% and for health counseling 92%. There were improvements in the 6-min-walk-distance (p=0.0013), sit-to-stand test (p=0.0062), the right and left biceps arm-curl tests p=0.0002 and p=0.0002, respectively; health-related quality of life (p=0.0209) (FACT-An), vitality (p=0.0015), mental health (p=0.0471) and physical component scale (p=0.0295) (SF36). Significant reduction in the symptom burden (p=0.0021) and symptom interference on daily life activities (p=0.0069) (MDASI). No adverse reactions were observed.
AB - This study investigates the feasibility, safety and benefits of a 6-week exercise and health counseling intervention in patients with acute leukemia undergoing consolidation chemotherapy during outpatient management. Seventeen of twenty patients completed study requirements (85%), adherence to exercise was 73% and for health counseling 92%. There were improvements in the 6-min-walk-distance (p=0.0013), sit-to-stand test (p=0.0062), the right and left biceps arm-curl tests p=0.0002 and p=0.0002, respectively; health-related quality of life (p=0.0209) (FACT-An), vitality (p=0.0015), mental health (p=0.0471) and physical component scale (p=0.0295) (SF36). Significant reduction in the symptom burden (p=0.0021) and symptom interference on daily life activities (p=0.0069) (MDASI). No adverse reactions were observed.
U2 - 10.1016/j.leukres.2012.09.001
DO - 10.1016/j.leukres.2012.09.001
M3 - Journal article
C2 - 23021021
VL - 37
SP - 155
EP - 161
JO - Leukemia Research
JF - Leukemia Research
SN - 0145-2126
IS - 2
ER -